Abstract. Considerable evidence implicates gp90 MEL as a lymphocyte homing receptor mediating lymphocyte attachment to high endothelial venules of lymph nodes in mouse. The protein appears to function as a calcium-dependent, lectin-like receptor as inferred primarily by the ability of specific carbohydrates to block its function and by the presence of a calcium-type lectin domain in its primary sequence. An ELISA assay is described which provides the first demonstration that the isolated protein has lectin activity and allows a further definition of its carbohydrate specificity. In addition to the monosaccharides mannose-6-phosphate and fructose-I-phosphate, ligand activity is shown for the sulfated glycolipid, sulfatide, and for two sulfated fucose-containing polysaccharides (fucoidin and egg jelly coat) from nonmammalian sources.
I
N most mammalian species, lymphocytes in the blood migrate into lymph nodes and other secondary lymphoid organs by first binding to the endothelium of specialized postcapillary venules known as high endothelial venules (HEVs) 1 (reviewed in Berg et al., 1989; Duijvestijn and Hamann, 1989; Rosen, 1989; Stoolman, 1989; Woodruff et al., 1987; Yednock and Rosen, 1989) . Over a period of several minutes, the lymphocytes migrate across the endothelium and its associated basement membrane and gain access to the parenchyma of the lymphoid organ where sequestered and processed antigens are encountered. The initiating adhesive interaction is mediated by a lymphocyte receptor, operationally termed a "homing receptor S that interacts with a complementary HEV-ligand expressed on the endothelial cells of HEV. The term "homing" conveys the general finding that different lymphocyte populations show differential adhesive specificities for HEV (reviewed in Butcher, 1986) . The term "vascular addressins" which has been applied to the HEV-ligands (Streeter et al., 1988a, b) , signifies that these adhesive ligands carry distinctive recognition determinants as a function of the anatomical site of the HEV. A current model of lymphocyte homing (Butcher and Weissman, 1984) , postulates that the complement of homing receptors expressed on a particular blood-borne lymphocyte is the primary factor in determining which lymphoid organs it can enter. Adhesion molecules such as LFA-1 appear to be accessory to the homing receptors in that they augment the strength of the lymphocyte-HEV interaction without imparting lymphoid organ selectivity (Hamann et al., 1988; Pals et al., 1988) . Two homing specificities, presumably based on two sets of nonoverlapping homing receptor/HEV-ligand 1. Abbreviations used in this paper: F1P, fructose-l-phosphate; HEV, high endothelial venule; M6P, mannose-6-phosphate; PN, peripheral lymph node; PP, Peyer's patch. pairs, have been described, directing lymphocyte binding to HEV in peripheral lymph nodes (PNs) and in Peyer's patches (PPs) (Butcher et al., 1980; Jalkanen et al., 1989; Schmitz et al., 1988) . Still other "homing specificities" may be involved in lymphocyte extravasation into other lymphoid compartments and into sites of inflammation outside of organized lymphoid organs (Jalkanen et al., 1986; Sackstein et al., 1988) . In the mouse, the best characterized homing receptor is gp90 mL, a =90-kD surface molecule defined by the mAb MEL-14 (Gallatin et ai., 1983) . When pretreated with this antibody, lymphocytes are unable to bind to PN HEV but bind normally to PP HEV as measured in an in vitro adherence assay (Stamper and Woodruff, 1976) . The occurrence of the MEL-14 mAb-defined epitope on various lymphocyte and lymphoma cell populations correlates with the ability of the cells to bind to PN HEV (Reichert et al., 1983) . Moreover, a direct adhesion role has recently been established for gp90 ~ by the finding that the isolated native protein (Geoffroy and Rosen, 1989) or a soluble recombinant form of the receptor (Watson et al., 1990) can interact selectively with PN HEV and block subsequent lymphocyte attachment.
A central aspect of the studies of gp90 mL concerns its function as a lectin-like receptor. Early studies revealed that D-marmose-6-phosphate (M6P) and o-fructose-l-phosphate (F1P), when compared to other phosphorylated monosaccharides, selectively inhibit the attachment of lymphocytes to PN HEV in rat (Stoolman et al., 1984) , mouse (Yednock et ai., 1987b) and human (Stoolman et al., 1987) . Additionally, the yeast-derived, M6P-rich phosphomannan monester core from Hansenula hostii known as PPME, and the sulfated, fucose-rich polysaccharide called fucoidin (from brown seaweed) were shown to be potent inhibitors of lymphocyte binding to PN HEV while having little effect on the binding of lymphocytes to PP HEV (Stoolman and Rosen, 1983; Yednock et al., 1987b, Yednock, T. A., M. S. Singer, Y. Imai, and S. D. Rosen, manuscript in preparation) . With PPME-derivatized microbeads as a probe for cell surface receptors, it was demonstrated that the carbohydrate dependency of lymphocyte binding to PN HEV can be accounted for by a calcium-dependent, lectin-like receptor on the lymphocyte surface (Yednock et al., 1987b; Stoolman et al., 1987; Stoolman and Ebling, 1989) . Moreover, experiments demonstrating MEL-14 mAb inhibition of PPME bead binding to lymphocytes and the coexpression of PPME bead binding with the MEL-14 epitope on lymphoma variants argued that the receptor, detected by PPME beads, was closely related and probably identical to gp90 uEL (Yednock et al., 1987a) . In agreement with this prediction, molecular cloning of gp90 MEL has revealed a transmembrane protein with a calcium-dependent ("C-type") lectin motif of 117 residues positioned at its extracellular amino terminus. Among the homologous proteins, the best known are the mammalian asialoglycoprotein receptors, the chicken hepatic lectin, and the mannose-binding protein, all of which show calcium-dependent carbohydrate-binding activity (reviewed by Drickamer, 1988) . The MEL-14-defined epitope has been shown to map to the amino terminal region of the "lectin" domain (Bowen et al., 1990) . Following the sugar-binding motif in the predicted sequence of gp90 MEL are an EFG-like motif (34 residues), two identical complement-regulatory motifs of 62 amino acids each, a transmembrane domain, and a short cytosolic tail of 17 amino acids. The arrangement of the three extracellular motifs (lectin/EGF/complement-regulatory) in this murine protein, its human homologue (Bowen et al., 1989; Tedder et al., 1989; Camerini et al., 1989; Tedder et al., 1990; Kishimoto et al., 1990) , and in two independent cell adhesion molecules (CAMs) (ELAM-1 [Bevilacqua et al., 1989] and GMP-140/PADGEM [Johnston et al., 1989] ) has led to the suggestion of the acronym LEC-CAM as a family designation (Stoolman, 1989 ). Bevilacqua, M. E, McEver, R. P., and co-workers (Geng et al., 1990) have proposed the name "selectins" for the family. The present study describes an ELISA assay that has been devised to measure the interaction between immunoaffinity-purified gp90 uEL and the carbohydrate-based ligand, PPME. The results described herein establish that gp90 MEL, as an isolated molecule, exhibits calcium-dependent lectin activity with the expected binding characteristics, including the ability to recognize fucoidin and a structurally related fucan from sea urchin egg jelly coat. The assay further reveals that a sulfated glycolipid of widespread occurrence in mammalian tissues (i.e., sulfatide) possesses ligand activity. It is concluded that the properties displayed by gp90 uEL in the ELISA assay account for critical adhesive functions manifested by this receptor at the lymphocyte surface.
Materials and Methods

Reagents
Bovine brain sulfatide [Cral(3-SO4)/31-1Ceramide], Gu3, galactosylceramide, cholesterol-3-sulfate, chondroitin sulfate A (bovine trachea), chondroitin sulfate B (porcine skin), chondroitin sulfate C (shark cartilage), colominic acid (E. coli), heparan sulfate (bovine intestinal mucosa), hyaluronic acid (human umbilical vein), keratan sulfate (bovine cornea), heparin (porcine intestinal mucosa), N-acetylneuraminic acid (E. coli), sialyllactose (85% ,2-3 linkage and 159[ c~2-6, from bovine colostrum), BSA (3-X crystallized), p-nitrophenylphosphate, polyoxyethylene sorbitan monolaurate (Tween 20), and ascorbic acid were purchased from Sigma Chemical Co. (St. Louis, MO). All of the phospborylated monosaccharides were from Sigma Chemical Co. and were in the sodium form except for GaI-I-P which was in the potassium form. Polyvinylsulfate (potassium salt) and sodium rhodizonate were from Aldrich Chemical Co. (Milwaukee, WI). An independent sample of brain sulfatide was purchased from Matreya, Inc. (Pleasant Gap, PA). Sulfatide was shown to be homogeneous by thin layer chromatography analysis. GMh GM2, Gnta, GD3, Crrtb, and GQlb were purchased from Calbiochem-Behring Corp. (La Jolla, CA); and C~tb from Bachem, Inc. (Torrance, CA). Synthetic Gal(6-SO4)/31-1Cer, fucoidin, and heparins (porcine mucosal and bovine lung) were generous gifts from Dr. D. Roberts (Laboratory of Structural Biology, National Institutes of Health, Bethesda, MD). Independent samples of fucoidin were purchased from ICN K&K Laboratories Inc. (Piainview, NY) and Sigma Chemical Co. PPME was purified from a crude yeast mannan preparation kindly provided by Dr. M. E. Slodki (Department of Agriculture, Northern Regional Research Center, Peoria, IL). Sea urchin egg jelly fucan from S. purpuratus was a generous gift of Dr. C. Glabe (Department of Molecular Biology and Biochemistry, University of California, Irvine, CA). Sulfate was determined by the bariumrhodizonate method described by Silvestri et al. (1982) . Biotinylated-goat anti-rabbit IgG (H +L) and Vectastain ABC-alkaline phosphatase kit were from Vector Laboratories, Inc. (Burlingame, CA). 3-[(3-cholamidopropyl)-dimethylammonio]-l-propanesulfonate (CHAPS) and octyl/3-D-glucopyranoside were from Boehringer Mannheim (Indianapolis, IN).
The anti-PPME antiserum was prepared by injecting a New Zealand white rabbit with 100/~g of PPME emulsified in 2 ml of Freund's complete adjuvant (Difco Laboratories Inc., Detroit, MI). The antigen was administered in multiple intradermal and subcutaneous sites, and the animal was bled 7 wk later.
ELISA Assay
gp90 MEL antigen, purified by immunoatiinity chromatography as previously described Geoffroy and Rosen, 1989) , was equilibrated in Dulbecco's PBS (0.68 mM calcium, 0.49 mM magnesium) containing either 1 mM CHAPS or 40 mM octyl/~-~glucopyranoside. The PPME-binding activity of gp90 Mm-appeared to be more stable in octyl/3-D-ghicopyranoside than in CHAPS. 10/~1 of antigen solution at specified concentrations was diluted into 90/~1 of PBS in the wells of Immulon-2 microtiter plates (Dynatech Laboratories, Inc., Chantilly, VA). The dilution factor was chosen to reduce the detergent concentration below the critical micellar concentration. Adsorption was allowed to proceed overnight at 4°C. The wells were washed three times with PBS containing 0.1% Tween 20 (PBS-Tween). 200/~1 of PBS containing 3% BSA and 0.02% NaN3 was then added to each well to block nonspecific binding sites. After a 2-h incubation at 22"C with agitation, the wells were washed and then received 100 /~1 of PPME solution in 3% BSA-PBS or 3% BSA-PBS alone (control for background). After a 1-h incubation at 4°C, the wells were washed to remove unbound polysaeehadde and 100/~1 of rabbit anti-PPME antiserum (1:100 dilution into 3% BSA in PBS-Twcen) was added to each well. This incubation and all subsequent incubations were allowed to proceed at 22"C with agitation. After 1 h of exposure to anti-PPME, the wells were washed and 100 t~l per well of biotinylated goat anti-rabbit IgG (1:200 dilution into 3 % BSA in PBS-Tween) was added and allowed to react for 1 h. The wells were again washed before the addition of 50/~1 per well of Vector ABC-AP reagent in PBS-Tween made according to the manufacturer's specifications. After 30 min, the wells were washed again and color development was initiated by the addition of 100/~1 per well of substrate solution (p-nitrophenyiphosphate, 1 mg/mi in 10 % [vol/vol] diethanolamine-HCl buffer, pH 9.8). Optical density readings were made at 405 nm with a (model 3550; BioRad Laboratories, Richmond, CA) microplate reader. Mean values were determined for two to three replicate wells. With PPME added in excess, a saturation level of binding was observed at ~0.4/~g of gp90 M~ per well. In experiments measuring the ability of substances to compete with PPME for binding to immobilized glO0 Mm~, a concentration of 0.2-0.5/~g per well of gp90 Mea~ was added and the substances (diluted into 50/~1 of PBS) were allowed to react with the antigen for 1 h at 4"C. PPME (50 t~l, in 6% BSA-PBS) was added to each well, and the plate was incubated for an additional 1 h at 4°C. The plate was then processed as described above. The concentrations of the inhibitors are expressed as final concentrations after addition of the PPME. To test lipids as inhibitors, samples dissolved in chloroformmethanol 1:1 were dried in glass test tubes under a stream of nitrogen, and then suspended in PBS by brief sonication (model D-50; Bransen Sonic Power Co., Chicago, IL). All of the inhibitory effects documented in this study were observed in at least two independent experiments.
In Vitro Lymphocyte-HEV Adherence Assay
The assay used was slightly modified from the original assay of Stamper and Woodruff (1976) . This highly validated assay measures the binding of lymphocytes to profiles of HEV exposed in cryostat-cut sections of lymphoid organs. Mouse peripheral lymph nodes (axillary, brachial, and cervical) were sectioned and processed as previously described (Stoolman et al., 1984) . Lymphocytes at 1 x 107 cells per ml were pretreated for 30 rain at 4°C with the aqueous suspension of lipids and then layered over paraformaldehyde-fixed tissue sections in the continued presence of the lipids. Lymphocyte attachment to HEV was measured by digital morphometry (Rosen et al., 1985) as the number of lympho~tes bound per unit area of HEV. Values were computed as percentages of control binding in the absence of inhibitors. Four to five replicate slides were used for each experimental condition and for the control condition.
Results
Development of an ELISA Assay
Our strategy took advantage of previous work in which transmembrane adhesion proteins have been coated onto plastic wells in a functionally active form (Martin and Springer, 1987; Staunton et al., 1989) . Immunoatiinity-purifled gpg0 MEL (>90% pure by SDS-PAGE analysis with silver staining visualization) suspended in either CHAPS or octyl/~-D-glucopyranoside detergent was diluted into Dulbecco's PBS (containing calcium and magnesium) to reduce the detergent concentration below the critical micellar concentration and then adsorbed overnight onto Immulon-2 microtiter wells. After washing of the wells and blockage of nonspecific sites with BSA, the wells were exposed to PPME in solution. PPME that bound to gp90 M~L in the wells was detected with an anti-PPME rabbit antiserum used in conjunction with a biotinylated second antibody and ABCalkaline phosphatase. Quantification was accomplished with a spectrophotometric microtiter plate reader. Fig. 1 A dem- onstrates that the binding of PPME to immobilized gp90 u~ increased with increasing amounts of gp90 MEL added to the wells. For a fixed amount of gp90 M~, saturation was approached at a PPME concentration of >10 #g/ml (Fig. 1 B) . Background, defined as the signal in the absence of added PPME, was subtracted from all values in these experiments and those that follow. Typically, this background represented <25-50% of the total signal but was very stable within each experiment. Assays carried out with preimmune serum produced <10% of the signal seen with the anti-PPME serum. To confirm that gp90 M~L and not a contaminant was responsible for the PPME interaction, the effect of the MEL-14 mAb was tested. As shown in Fig. 2 , this antibody completely inhibited binding of PPME, whereas the class-matched control antibody anti-T200 (30G12, anti-CD45) had no significant effect. As expected for a calcium-dependent lectin interaction, EGTA at 10 mM, which reduced free calcium to '~10 -9 M, completely blocked the interaction with PPME (Fig. 2) . In a quantitative study of the calcium requirement, half-maximal binding of PPME to gp90 M~L occurred at '~,10 -5 M Ca ~ in the presence or absence of 1 mM magnesium (Yednock, T. A., M. S. Singer, Y. Imai, and S. D. Rosen, manuscript in preparation).
Effects of Monosaccharides and Polysaccharides
Our previous results established that M6P and F1P were selective inhibitors of in vitro lymphocyte binding to PN HEV as compared to mannose-l-phosphate, fructose-6-phosphate and several other phosphorylated monosaccharides. When tested in the ELISA assay, these monosaccharides exhibited a similar inhibitory profile. 50% inhibition of PPME binding to gpg0 MEL (Fig. 3 ) was achieved at 7 mM for both 0.6. 0.5. M6P and F1P, respectively, while M1P and F6P required twoto threefold higher concentrations. Galactose-l-phosphate, galactose-6-phosphate, and glucose-l-phosphate were equivalent to F6P (not shown). These differences among the phosphorylated monosaccharides were statistically significant and were consistently observed in several experiments with different batches of sugars. Neutral monosaccharides (D-mannose, L-fucose, D-fucose, D-fructose, and D-galactose) were inactive in this assay at >400 mM (data not shown). Also, sialic acid as free 5 N-acetylneuraminic acid (Neu5Ac) or as sialyllactose was three-to fivefold less active on a molar basis than M6P (not shown) and thus was comparable to F6P and the other relatively inactive phosphorylated monosaccharides. Among the charged polysaccharides, fucoidin and sea urchin egg jelly fucan (a sulfated fucose homopolysaccharide) were both very potent inhibitors on a mass basis in the ELISA assay (Fig. 4 A) . With three different preparations of fucoidin in several experiments, 50% inhibition was observed at 0.1-0.4/xg/ml, equivalent to 1-4 nM, based on an average molecular weight of 100,000 D (Roberts and Ginsberg, 1988) . Hence, on a molar basis, fucoidin was six orders of magnitude more potent than M6P. The egg jelly fucan, with a molecular weight >106 D was even more active than fucoidin per unit molecule. Other charged polysaccharides, including chondroitin sulfates A, B, and C, heparan sulfate, keratan sulfate, hyaluronic acid, and colominic acid (a homopolymer of ~ 2-8 linked sialic acid) were at least 3,000-fold less active per unit weight than fucoidin or egg jelly fucan. On the basis of sulfate concentration, fucoidin and egg jelly fucan were also three orders of magnitude more effective than the other sulfated polysaccharides (Fig. 4 B) as well as polyvinylsulfate, a highly sulfated hydrocarbon. A direct comparison of the sulfate content of the various sulfated compounds established that sulfate content was not correlated with inhibitory efficacy (Table I) .
Effects of Glycolipids
Preliminary experiments (True, D. D., unpublished observations) had suggested that microspheres coated with sulfatide (i.e., Gal(3-SO4)/31-1-Cer) could bind to mouse lymphocytes. Since this interaction was partially inhibited (•50%) by MEL-14 mAb and by EDTA, it seemed likely that sulfatide possessed ligand activity for gp90 MEL. To explore this possibility further, we determined whether brain sulfatide in an aqueous suspension could inhibit the binding of PPME to gp90 MEL in the ELISA assay. Sulfatide at 10/~g/ml almost completely prevented PPME binding to immobilized gp90 M~- (Table II) with 50% inhibition at '~1 /~g/ml or 1 /xM SO4 (Fig. 4) . Gal(6-SO4)fll-lCer, cholesterol 3-SO4, galactosylceramide (Galfll-lCer), and several gangliosides (GM1, GD~a, GDIb, Gzlb) had no activity at the same concentration and much less, if any, activity when tested at a 10-fold higher concentration (Table U) . Additionally, the gangliosides GM2, GM3, GD3, and GQtb showed little or no activity at 100 t~g/ml.
Effect of Sulfaade on Lymphocyte Binding to HEV
Consistent with the inhibitory effect of sulfatide on gp90 MEL in the ELISA assay, this glycolipid also blocked lymphocyte attachment to PN HEV in a dose-dependent manner in the in vitro adherence assay, whereas Gal(6-SO4)-Cer and cholesterol-3-SO4 displayed minimal activity (Fig. 5) . None of the lipids adversely affected the viability of the test lymphocytes, as determined by trypan blue exclusion.
Discussion
Our previous studies had indicated a close relationship between the calcium-dependent, lectin-like receptor detected on the lymphocyte cell surface by PPME and the protein (i.e., gp90 ~EL) recognized by the adhesion-blocking mAb, MEL-14. The finding of a C-type lectin domain at the extracellular terminus of gp90 MEL lent strong support to the contention that the relationship was one of identity. Here, we establish identity by showing directly that immunoaffinity- purified gp90 MEL, immobilized on plastic, can bind to PPME with the predicted characteristics. As determined in the ELISA assay, the interaction is saturable, calciumdependent, and selectively inhibited by MEL-14 mAb. With respect to sugar inhibition, MtP and F1P are two to threefold more active than M1P and F6P in competing PPME binding to gp90 MEL, in agreement with the relative activities of these sugars in blocking both PPME bead binding to lym- The substances listed were analyzed for sulfate content. The valfies represent means of duplicate determinations. The half-range variations were <2 % of the means in all cases. Substances are listed in order of increasing sulfate content. Concentrations for 50% inhibition in the ELISA assay were determined from the dose-response curves of Fig. 4 and from dose-response curves not shown.
phocytes and lymphocyte attachment to PN HEV (Yednock et al., 1987b) . Fucoidin, a fucose-rich polysaccharide with sulfation primarily on the 4-position of fucose (DeAngelis and Glabe, 1987) , is substantially more potent than PPME as an inhibitor of lymphocyte attachment to PN HEV (Yednock et al., 1987b; Stoolman et al., 1984) . Heretofore, it has not been clear whether this polysaccharide achieves inhibition of lymphocyte attachment to HEV by binding to the same subsite of gp90 M~L or even to the same receptor as PPME (Brandley et al., 1987; Yednock et al., 1987a) . We have now shown that fucoidin directly blocks PPME binding to gp90 MEL in the ELISA assay and thus appears capable of a direct interaction with this lymphocyte receptor. The sea urchin egg jelly fucan, a homopolysaccharide of L-fucose with sulfation on the C-4 position of the sugar and hence clearly related to fucoidin (DeAngelis and Glabe, 1987) , is even more active as an inhibitor. Testing of several other charged polysaccharides (hyaluronic acid, colominic acid, heparins, chondroitin sulfates, and keratan sulfate) and a sulfated hydrocarbon, many of which have charge densities comparable to or exceeding that of the fucans (Table I ; DeAngelis and Glabe, 1987) , establishes that the inhibitory effects of the fucans are highly selective and cannot merely be explained on the basis of charge density.
In an attempt to identify additional carbohydrate-based inhibitors of the PPME/gp90 M~ interaction, we tested a series of glycolipids in the ELISA assay. Sulfatide [Gal(3-SO,)~l-lCer], which preliminary experiments indicated might interact with gp90 M~, is now confirmed to be active, In contrast, cholesterol-3-sulfate and the synthetic glycolipid, Gal(6-SO4)/31-1Cer are substantially less active. The presence of the sulfate moiety is critical to sulfatide's activity, since galactosylceramide (Gal/31-1Cer) is inactive. The functional relevance of these observations with the ELISA assay Sulfatule ( is borne out by direct lymphocyte adhesion assays Sulfatlde, hke PPME and fucoldm, inhibits lymphocyte attachment to PN HEV m the Stamper-Woodruff m wtro adherence assay, while Gal(6-SO0~l-lCer and cholesterol-3-sulfate are essentially macUve at the concentrations tested On a molar bas~s, Gal(3-SO0~l-lCer is over three orders of magmtude more potent than M6P m both the m wtro adherence assay and the ELISA assay It seems probable that the enhanced efficacy of sulfatade (monomerlc molecular weight of 807) relatave to M6P and F1P derives, at least m part, from its nucellar orgamzataon m aqueous solution Smularly, the high avlchty of PPME for munobthzed gp90 u~- (Fig 1 B) is hkely attributable to the muluvalent presentaUon of M6P residues m the polysacchande The C-type lecUn domain of gp90 M~L is almost certainly revolved m the binding of the intact receptor to PPME In ad&Uon to the sugar selecuvlty of the mteracuon and the requirement for calcmm (two hallmarks of a C-type lectm), PPME binding is blocked by the MEL-14 mAb, which detects an epltope in the lectm domain of gp90 MEL (Bowen et al , 1990) Based on their acUvlty m competang PPME binding m the ELISA assay, it seems hkely that the fucans as well as sulfaUde also mteract with the lectm domain of gp90 MBL, F, gure 5 Effects of sulfated hp~ds on lymphocyte attachment to PN HEV Lymphocytes, exposed to hplds at the m&cated concentrauons, were tested for their ability to attach to PN HEV m the Stamper-W6bdruff m wtro adherence assay as described m Materials and Methods Binding is computed as a p~reentage of the control value deterrmned m the absence of added hpld Error bars denote SEMs computed from four to five replicate tissue sectaons The symbols are (A) sulfaude, (~) Gal(6-SO4)Bl-lCer, and (.) cholesterol-3-SO4 but these pre&caons remain to be confirmed m &feet binding assays.
It would be saUsfymg to account for the most acuve carbohydrates in the ELISA assay on the basis of some common structural moUf M6P and F1P do share structural features, which appear to account for their highly selecuve binding to lysosomal somng receptors (Tong and Kornfeld, 1989) However, m the case of the gp90 MEL the thfference m potency between these sugars and the other phosphorylated sugars is not sufficiently great to warrant the proposal of a detailed model Moreover, our finding that fucans and sulfatlde are highly acuve relative to other charged polysacchandes and glycollplds does not justify modeling on the basis of their consUtuent sugars 0 e, fucose-4-sulfate and galactose-3-sulfate), since the potentaal contrlbutaons of glycosl&c hnkage and mulUvalency to the acUwty of these glycoconjugates are not known at present The eventual ~den-aficaUon of monosaccharldes or structurally-defined ohgosaccharldes with potent and selecUve inhibitory actlviUes will greatly facflRate efforts to elucidate the cnUcal features of carbohydrate structure requLred for rec, ograUon by gp90 u~ Our previous work has shown that gp90 MsL funcUons as an adhesion molecule by binding directly to the endothehum of PN HEV through an lnteracuon with an as yet uncharacterlzed HEV-hgand It Is also known that the lectm actwlty of gp90 MEL is reqmred for Rs mteracUon with the endothelmm (Geoffrey and Rosen, 1989 , Watson et al, 1990 Consequently, mhlbRory sugars for gp90 MBL (e g, M6E F1P, etc ) are presumed to be structural mmucs of a carbohydrate recogmUon determinant present on the HEV-hgand Since the mhlbRory sugars are all anlomc, R is strongly suspected that the actual recogmUon determinant is a negauvely charged carbohydrate Addluonally, the fact that the C-type lectm motif of gp90 MEL contains significantly more basic attune acids than any other member of this lectin family is consistent with the possibility of a negatively charged sugar ligand (Lasky et al., 1989) . In this regard, it is intriguing that the PN HEV-ligand is inactivated by sialidases or by pretreatment of the HEV with L/maxflavus agglutinin, a sialic acidspecific lectin (Rosen et 
